Shares of Sun Pharmaceutical Industries Ltd surged 7.75 percent after the company reported better-than-expected June quarter results.
The scrip traded at Rs 606.35, rising by Rs 43.60 on the BSE at 2:50 PM.
Intra-day, it touched a high of Rs 606.80 and a low of Rs 560.40, after opening at Rs 566.20.
The pharma company reported a net profit of Rs 983 crore ($140.6 million) for the three months ended June 30, compared with a loss of Rs 425 crore a year ago.
In the year-ago quarter, Sun Pharma incurred costs of Rs 951 crore related to settlements in a US antitrust case over sleep disorder drug Modafinil.
Analysts on average expected a net profit of Rs 897 crore. Total revenue from operations rose about 16 percent to Rs 7,224 crore.
The Nifty Pharma surged by 3.22 percent, rising by nearly 296 points, to 9,482.50.
Also, catch all the action and updates in our Market Live blog
.
Check out our in-depth Market Coverage, Business News & get real-time Stock Market Updates on CNBC-TV18. Also, Watch our channels CNBC-TV18, CNBC Awaaz and CNBC Bajar Live on-the-go!
Odisha's new CM — who is Mohan Charan Majhi and what prompted the BJP to choose him
Jun 13, 2024 2:54 PM
Election 2024: 504 out of 543 newly-elected MPs are ‘crorepatis’ – Check 10 richest members in 18th Lok Sabha
Jun 12, 2024 9:55 PM
BJP to start nationwide organisational rejig, new party president to be elected soon
Jun 12, 2024 9:31 AM
New Lok Sabha Speaker to be elected in special 8-day session: Report
Jun 11, 2024 6:28 PM